SETD1A and breast cancer: Consistent with these data, ERα mRNA levels in ER-positive breast cancer tissues were significantly higher in the cancer tissues with high expression of MLL3 or SET1A, as assessed based on the analysis of the publicly available breast cancer data sets (Fig. 2d) [33–35].